Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07493252 · ClinicalTrials.gov registry record · NA
A Behavioral Application for Improving Smoking Cessation Among Smokers
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 1,812
- Enrollment target
NCT07493252: Clinical Trial NA study, sponsored by Fred Hutchinson Cancer Center.
NCT07493252 is a NA study that has not yet begun recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 1,812 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07493252, a NA study, has not yet begun recruiting, sponsored by Fred Hutchinson Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,812 participants
- Enrollment target
Study Summary
This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behaviors such as smoking. The Actify! B app provides evidence-based tobacco cessation strategies based on current clinical guidelines.
Primary Outcome
Percentage of participants self-reporting no smoking over the previous 30 days
Interventions
- OTHER Survey Administration
- OTHER Health Promotion and Education
- BEHAVIORAL Smartphone app-based Intervention (Actify! A app)
- BEHAVIORAL Smartphone app-based Intervention (Actify! B app)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,812 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2029-07-31 |
| Phase | NA |
What is known before NCT07493252 opens enrollment
NCT07493252 is an interventional study that assigns participants to a tested intervention. Its 1,812 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% higher).
The record links to 0 conditions, and to 4 interventions - of which Survey Administration is the first listed.
NCT07493252 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07493252 about?
NCT07493252 is a clinical study titled "A Behavioral Application for Improving Smoking Cessation Among Smokers". This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behavi...
What is the current status of trial NCT07493252?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,812 participants. The study started on 2026-08-01. Estimated completion is 2029-07-31.
What interventions are being tested in trial NCT07493252?
The interventions under investigation include: Survey Administration (OTHER), Health Promotion and Education (OTHER), Smartphone app-based Intervention (Actify! A app) (BEHAVIORAL), Smartphone app-based Intervention (Actify! B app) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07493252?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07493252's enrollment target sits among peer trials
1,812 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI